SCHEMBL10735503

SCHEMBL10735503

C#C[S+]([O-])c1ccc(-c2nc3cnncc3[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.38
▸ RAB9A P51151 7/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ KDM4E B2RXH2 6/20 0.38
▸ SMN1; SMN2 Q16637 6/20 0.38
▸ PKM P14618 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ AURKA O14965 1/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ RXFP1 Q9HBX9 2/20 0.35
▸ CACNA1B Q00975 1/20 0.35
▸ APBA1 Q02410 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ MAPT P10636 4/20 0.34
▸ GFER P55789 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ RECQL P46063 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10735012 0.84 NPC1 (0.36) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10737121 0.81 AURKA (0.40) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10739174 0.78 AURKA (0.38) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10736236 0.78 AURKA (0.38) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10737729 0.77 NPC1 (0.36) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10738000 0.76 NPBWR1 (0.39) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10736239 0.75 CHEK1 (0.41) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10741021 0.75 AURKA (0.36) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10741861 0.75 ALDH1A1 (0.35) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2
SCHEMBL10739641 0.74 ALDH1A1 (0.42) NPC1RAB9AALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4654344-A ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US disclosed
EP-0093951-B1 2-ARYL-TETRAAZAINDENES MERCK PATENT GmbH (DE) 1986-10-29 — — EP disclosed
US-4575505-A Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1986-03-11 — — US disclosed
US-4477454-A INDOTROPIC AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-16 — — US disclosed
EP-0093951-A2 2-Aryl-tetraazaindenes MERCK PATENT GmbH (DE) 1983-11-16 — — EP disclosed
Send feedback